Strategic Analysis 2025

RELX

Information & Analytics: Empowering Decision-Makers Globally

London, UK

$111.4B Market Cap

Executive Summary

RELX at a Glance

£9.0B

2024 Revenue

+7.2% vs 2023 (£8.4B)

£2.9B

Adjusted Op Profit

32.2% margin, +9.1% vs 2023

$111.4B

Market Cap

Premium info services

Information & Analytics

Global leader in information-based analytics with 35,000+ employees serving customers in 180+ countries. Transforming data into actionable insights.

Four Business Segments

Scientific (Elsevier), Legal (LexisNexis), Risk (Insurance), and Exhibitions (RX). Each segment a market leader with strong competitive moats.

AI & Digital Transformation

Leading AI integration across products, 85% digital revenue, and advanced analytics capabilities. Driving productivity and customer value enhancement.

Capital Efficiency

Strong cash conversion (95%+), 32.2% operating margin, and disciplined capital allocation. £1.8B shareholder returns in 2024 with progressive dividend.

Strategic Focus

Accelerating digital transformation while maintaining market-leading positions

85%

Digital Revenue

Business Portfolio

Four-Market Leadership

Scientific

£2.9B

Revenue (32% of total)

Elsevier - global #1

Scopus, ScienceDirect

2.5M+ articles/year

Legal

£2.4B

Revenue (27% of total)

LexisNexis - global leader

Legal analytics & AI

40M+ legal documents

Risk

£2.1B

Revenue (23% of total)

Insurance analytics

Fraud detection

Compliance solutions

Exhibitions

£1.6B

Revenue (18% of total)

RX - global leader

400+ events annually

Digital-first approach

Revenue by Business Segment (2024)

Market Leadership

#1 or #2 positions in all four business segments with strong competitive moats

Strategic Initiatives

AI & Digital Leadership

85%

Digital Revenue

2024

300M+

User Profiles

Analytics

£500M+

Tech Investment

2020-2025

AI Integration Across Portfolio

Scientific AI

Elsevier's AI-powered research tools, automated literature reviews, and predictive analytics accelerating scientific discovery and drug development.

Drug discovery acceleration

Legal AI

LexisNexis Lexis+ AI for legal research, contract analysis, and predictive litigation outcomes. Transforming legal workflows and efficiency.

Platform & Data Strategy

Elsevier SciVal

AI-Driven

Research performance analytics with AI-powered recommendations and benchmarking for universities and governments.

LexisNexis Risk

Predictive

AI-powered fraud detection, identity verification, and compliance monitoring for financial institutions and governments.

RX Digital

Hybrid

Digital-first exhibitions with AI-powered matchmaking, virtual platforms, and data-driven networking experiences.

Digital Leadership

Leading digital transformation with AI-powered analytics and decision tools

95%+

Cash Conversion

Financial Performance

2024 Financial Results

£9.0B

Revenue

+7.2% YoY

£2.9B

Adj Op Profit

32.2% margin

£2.5B

Free Cash Flow

27.8% margin

£1.8B

SH Returns

72% payout

1.8x

Net Debt/EBITDA

Comfortable

Revenue & Profitability Trend

Key Financial Metrics

Underlying Revenue Growth 5.5%

Consistent growth

Adjusted EPS Growth 9.8%

Strong earnings growth

Cash Conversion 95%+

World-class conversion

Dividend per Share 58.0p

Progressive dividend policy

Financial Excellence

Strong margins, cash conversion, and consistent growth trajectory

32.2%

Operating Margin